School of Basic Medical Science, Hebei University, Baoding, Hebei, P. R. China.
College of Traditional Chinese Medicine, Hebei University, Baoding, Hebei, P. R. China.
J Pharm Pharmacol. 2023 Apr 17;75(5):585-592. doi: 10.1093/jpp/rgac103.
To review the pharmacokinetics, pharmacological action and mechanism of isoalantolactone (IAL). Explore the therapeutic potential of isoalantolactone.Keywords including isoalantolactone, pharmacological effects, pharmacokinetic and toxicity were used for literature search in PubMed, Excerpta Medica Database (EMBASE) and Web of Science, to identify articles published from 1992 to 2022.
IAL has a great many obiological activities such as anti-inflammatory, antioxidant, antitumour, neuroprotection, with no obvious toxicity. This review suggests that IAL exerts different pharmacological effects with different mechanisms of action at different doses, and may be a potential drug candidate to treat inflammatory diseases, neurodegenerative diseases and cancer, with medicinal value.
IAL has various pharmacological activities and medicinal values. However, further research is needed to determine its specific intracellular action sites and targets, so as to fully understand its therapeutic mechanism and provide a reference for the treatment of related diseases.
综述土木香内酯(IAL)的药代动力学、药理作用及作用机制。探讨土木香内酯的治疗潜力。关键词包括土木香内酯、药理作用、药代动力学和毒性,在 PubMed、Excerpta Medica Database(EMBASE)和 Web of Science 中进行文献检索,以确定 1992 年至 2022 年发表的文章。
IAL 具有多种生物学活性,如抗炎、抗氧化、抗肿瘤、神经保护作用,且毒性不明显。本综述表明,IAL 在不同剂量下通过不同的作用机制发挥不同的药理作用,可能是治疗炎症性疾病、神经退行性疾病和癌症的潜在候选药物,具有药用价值。
IAL 具有多种药理作用和药用价值。然而,需要进一步研究以确定其特定的细胞内作用部位和靶点,从而充分了解其治疗机制,并为相关疾病的治疗提供参考。